Valuation Analysis in Pharmaceutical Licensing and …

Valuation Analysis in Pharmaceutical Licensing and M&A transactions A Tutorial By Tim Opler, Benj Garrett and Susan Langer January 2014 2 I AGENDA Agenda Discuss role of Valuation and project assessment Introduce Valuation tools Show how to use the tools in business development Go over a variety of cases 3 I Table of Contents Creation and Business Development of Pharmaceutical Projects Forecasting Estimation Estimation Discount Rate Considerations in Licensing Considerations in M&A V A L U E C R E A T I O N A N D B U S I N E S S D E V E L O P M E N T 5 I VALUE IS CREATED BY INVESTMENT FOR FUTURE PROFIT Typical Value Creating Profile -100-50050100150200250300350123456789101 11213 Revenues and Costs Over Time ($ millions) Acquisition CostR&DLaunch CostSelling CostOther CostRevenue6 I PROCESS Value Creation Process Finding projects that fit Assessing the projects Negotiating deals for the projects in the face of competition Delivering on the potential of the projects Realizing the value Assessment and negotiation calls for strong Valuation and Analysis work.

Valuation Analysis in Pharmaceutical Licensing and M&A Transactions A Tutorial By Tim Opler, Benj Garrett and Susan Langer January 2014

Loading..

Tags:

  Analysis, Pharmaceutical, Transactions, Licensing, Valuation, Valuation analysis in pharmaceutical licensing, Valuation analysis in pharmaceutical licensing and m amp a transactions

Information

Related search queries